Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
February-2019 Volume 17 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2019 Volume 17 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Ebselen protects rat hearts against myocardial ischemia‑reperfusion injury

  • Authors:
    • Bin Cheng
    • Jin‑Peng Zhong
    • Fu‑Xia Wu
    • Guan‑Lan Li
    • Qing‑Xiao Ruan
    • Gang Luo
    • Hong Jiang
  • View Affiliations / Copyright

    Affiliations: Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China, Department of Cardiology, The People's Hospital of China Three Gorges University, Yichang, Hubei 443000, P.R. China
  • Pages: 1412-1419
    |
    Published online on: December 12, 2018
       https://doi.org/10.3892/etm.2018.7089
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Ebselen is an organoselenium compound that has demonstrated potent antioxidant and anti‑inflammatory effects in previous studies. The present study was conducted to evaluate the effect of ebselen on myocardial ischemia‑reperfusion (I/R) injury in a rat model and to elucidate the related mechanisms. Myocardial infarct size was assessed using triphenyltetrazolium chloride staining. Myocardial injury was evaluated according to the histopathological and ultrastructural alterations of rat hearts and the serum activity levels of cardiac enzymes, including creatine kinase (CK), CK‑MB isoenzyme and lactate dehydrogenase (LDH). Cardiomyocyte apoptosis was detected using the terminal dUTP nick end‑labelling (TUNEL) assay. In addition, the expression of apoptosis‑associated proteins was measured using western blot analysis. In heart tissue specimens the activity of superoxide dismutase (SOD) and glutathione peroxidase (GPx), and levels of malondialdehyde (MDA) and protein carbonyl (PC) were also detected. The results indicated that ebselen reduced I/R‑induced increase in myocardial infarct size and prevented the I/R‑induced decreases in ejection fraction and fractional shortening. Further of note, ebselen improved I/R‑induced rat heart injury. This was indicated by attenuation of histological and ultrastructural changes; reduction of serum CK, CK‑MB and LDH activity levels; and decreased cell apoptosis on TUNEL staining, which was verified by decreased expression of cleaved (C)‑Caspase‑8, C‑Caspase‑3, B‑cell lymphoma 2 (Bcl‑2)‑associated X protein and C‑PARP, and increased expression of Bcl‑2. Additionally, SOD and GPx activity levels were significantly higher, while MDA and PC levels were significantly lower in the ebselen + I/R group compared with in the I/R group. In conclusion, the present results suggested that ebselen serves an important role in protecting against myocardial I/R injury. The underlying mechanism may involve suppression of cardiomyocyte apoptosis and promotion of antioxidant activity.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Li C and Jackson RM: Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol. 282:C227–C241. 2002. View Article : Google Scholar : PubMed/NCBI

2 

Mochizuki K, Ohno Y, Kanematsu T, Sakurai-Yamashita Y, Niwa M, Hishikawa Y and Koji T: Possible protection of sinusoidal endothelial cells by endothelin B receptor during hepatic warm ischemia-reperfusion. Surg Today. 37:460–467. 2007. View Article : Google Scholar : PubMed/NCBI

3 

Fröhlich GM, Meier P, White SK, Yellon DM and Hausenloy DJ: Myocardial reperfusion injury: Looking beyond primary PCI. Eur Heart J. 34:1714–1722. 2013. View Article : Google Scholar : PubMed/NCBI

4 

Diez ER, Altamirano LB, García IM, Mazzei L, Prado NJ, Fornes MW, Carrión FD, Zumino AZ, Ferder L and Manucha W: Heart remodeling and ischemia-reperfusion arrhythmias linked to myocardial vitamin d receptors deficiency in obstructive nephropathy are reversed by paricalcitol. J Cardiovasc Pharmacol Ther. 20:211–220. 2015. View Article : Google Scholar : PubMed/NCBI

5 

Elahi MM, Kong YX and Matata BM: Oxidative stress as a mediator of cardiovascular disease. Oxid Med Cell Longev. 2:259–269. 2009. View Article : Google Scholar : PubMed/NCBI

6 

Tahara EB, Navarete FD and Kowaltowski AJ: Tissue-, substrate-, and site-specific characteristics of mitochondrial reactive oxygen species generation. Free Radic Biol Med. 46:1283–1297. 2009. View Article : Google Scholar : PubMed/NCBI

7 

Vassalle C, Pratali L, Boni C, Mercuri A and Ndreu R: An oxidative stress score as a combined measure of the pro-oxidant and anti-oxidant counterparts in patients with coronary artery disease. Clin Biochem. 41:1162–1167. 2008. View Article : Google Scholar : PubMed/NCBI

8 

Rodrigo R, Libuy M, Feliú F and Hasson D: Oxidative stress-related biomarkers in essential hypertension and ischemia-reperfusion myocardial damage. Dis Markers. 35:773–790. 2013. View Article : Google Scholar : PubMed/NCBI

9 

Katsumi H, Nishikawa M, Yasui H, Yamashita F and Hashida M: Prevention of ischemia/reperfusion injury by hepatic targeting of nitric oxide in mice. J Control Release. 140:12–17. 2009. View Article : Google Scholar : PubMed/NCBI

10 

Taki-Eldin A, Zhou L, Xie HY, Chen KJ, Yu D, He Y and Zheng SS: Triiodothyronine attenuates hepatic ischemia/reperfusion injury in a partial hepatectomy model through inhibition of proinflammatory cytokines, transcription factors, and adhesion molecules. J Surg Res. 178:646–656. 2012. View Article : Google Scholar : PubMed/NCBI

11 

Scott MD, Lubin BH, Zuo L and Kuypers FA: Erythrocyte defense against hydrogen peroxide: Preeminent importance of catalase. J Lab Clin Med. 118:7–16. 1991.PubMed/NCBI

12 

Sabri A, Hughie HH and Lucchesi PA: Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes. Antioxid Redox Signal. 5:731–740. 2003. View Article : Google Scholar : PubMed/NCBI

13 

Li C, Hu M, Wang Y, Lu H, Deng J and Yan X: Hydrogen sulfide preconditioning protects against myocardial ischemia/reperfusion injury in rats through inhibition of endo/sarcoplasmic reticulum stress. Int J Clin Exp Pathol. 8:7740–7751. 2015.PubMed/NCBI

14 

Wang Q, Lin P, Li P, Feng L, Ren Q, Xie X and Xu J: Ghrelin protects the heart against ischemia/reperfusion injury via inhibition of TLR4/NLRP3 inflammasome pathway. Life Sci. 186:50–58. 2017. View Article : Google Scholar : PubMed/NCBI

15 

Hu SY, Zhang Y, Zhu PJ, Zhou H and Chen YD: Liraglutide directly protects cardiomyocytes against reperfusion injury possibly via modulation of intracellular calcium homeostasis. J Geriatr Cardiol. 14:57–66. 2017.PubMed/NCBI

16 

Ozaki M, Nakamura M, Teraoka S and Ota K: Ebselen, a novel anti-oxidant compound, protects the rat liver from ischemia-reperfusion injury. Transpl Int. 10:96–102. 1997. View Article : Google Scholar : PubMed/NCBI

17 

Denicola A and Radi R: Peroxynitrite and drug-dependent toxicity. Toxicology. 208:273–288. 2005. View Article : Google Scholar : PubMed/NCBI

18 

National Research Council (US) Institute for Laboratory Animal Research: Guide for the Care and Use of Laboratory Animals. National Academies Press (US); Washington, DC: 1996

19 

Paglia DE and Valentine WN: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 70:158–169. 1967.PubMed/NCBI

20 

Snow-Lisy DC, Sabanegh ES Jr, Samplaski MK, Morris VB and Labhasetwar V: Superoxide dismutase-loaded biodegradable nanoparticles targeted with a follicle-stimulating hormone peptide protect Sertoli cells from oxidative stress. Fertil Steril. 101:560–567. 2014. View Article : Google Scholar : PubMed/NCBI

21 

Ohkawa H, Ohishi N and Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 95:351–358. 1979. View Article : Google Scholar : PubMed/NCBI

22 

Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S and Stadtman ER: Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186:464–478. 1990. View Article : Google Scholar : PubMed/NCBI

23 

Narula J, Hajjar RJ and Dec GW: Apoptosis in the failing heart. Cardiol Clin. 16:691–710. 1998. View Article : Google Scholar : PubMed/NCBI

24 

Piper HM, García-Dorado D and Ovize M: A fresh look at reperfusion injury. Cardiovasc Res. 38:291–300. 1998. View Article : Google Scholar : PubMed/NCBI

25 

Yellon DM and Hausenloy DJ: Myocardial reperfusion injury. N Engl J Med. 357:1121–1135. 2007. View Article : Google Scholar : PubMed/NCBI

26 

Hausenloy DJ and Yellon DM: Myocardial ischemia-reperfusion injury: A neglected therapeutic target. J Clin Invest. 123:92–100. 2013. View Article : Google Scholar : PubMed/NCBI

27 

Zweier JL, Flaherty JT and Weisfeldt ML: Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA. 84:1404–1407. 1987. View Article : Google Scholar : PubMed/NCBI

28 

Heusch G, Boengler K and Schulz R: Inhibition of mitochondrial permeability transition pore opening: The Holy Grail of cardioprotection. Basic Res Cardiol. 105:151–154. 2010. View Article : Google Scholar : PubMed/NCBI

29 

Vinten-Johansen J: Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res. 61:481–497. 2004. View Article : Google Scholar : PubMed/NCBI

30 

Guven A, Tunc T, Topal T, Kul M, Korkmaz A, Gundogdu G, Onguru O and Ozturk H: Alpha-lipoic acid and ebselen prevent ischemia/reperfusion injury in the rat intestine. Surg Today. 38:1029–1035. 2008. View Article : Google Scholar : PubMed/NCBI

31 

Hamacher J, Stammberger U, Weber E, Lucas R and Wendel A: Ebselen improves ischemia-reperfusion injury after rat lung transplantation. Lung. 187:98–103. 2009. View Article : Google Scholar : PubMed/NCBI

32 

Kizilgun M, Poyrazoglu Y, Oztas Y, Yaman H, Cakir E, Cayci T, Akgul OE, Kurt YG, Yaren H, Kunak ZI, et al: Beneficial effects of N-acetylcysteine and ebselen on renal ischemia/reperfusion injury. Ren Fail. 33:512–517. 2011. View Article : Google Scholar : PubMed/NCBI

33 

Ozyigit F, Kucuk A, Akcer S, Tosun M, Kocak FE, Kocak C, Kocak A, Metineren H and Genc O: Different dose-dependent effects of ebselen in sciatic nerve ischemia-reperfusion injury in rats. Bosn J Basic Med Sci. 15:36–43. 2015. View Article : Google Scholar : PubMed/NCBI

34 

Baljinnyam E, Hasebe N, Morihira M, Sumitomo K, Matsusaka T, Fujino T, Fukuzawa J, Ushikubi F and Kikuchi K: Oral pretreatment with ebselen enhances heat shock protein 72 expression and reduces myocardial infarct size. Hypertens Res. 29:905–913. 2006. View Article : Google Scholar : PubMed/NCBI

35 

Hori M and Nishida K: Oxidative stress and left ventricular remodelling after myocardial infarction. Cardiovasc Res. 81:457–464. 2009. View Article : Google Scholar : PubMed/NCBI

36 

Zhou S, Sun W, Zhang Z and Zheng Y: The role of Nrf2-mediated pathway in cardiac remodeling and heart failure. Oxid Med Cell Longev. 2014:2604292014. View Article : Google Scholar : PubMed/NCBI

37 

Maulik N and Yoshida T: Oxidative stress developed during open heart surgery induces apoptosis: Reduction of apoptotic cell death by ebselen, a glutathione peroxidase mimic. J Cardiovasc Pharmacol. 36:601–608. 2000. View Article : Google Scholar : PubMed/NCBI

38 

Chen Y, Liu J, Li S, Yan F, Xue Q, Wang H, Sun P and Long C: Histidine-tryptophan-ketoglutarate solution with added ebselen augments myocardial protection in neonatal porcine hearts undergoing ischemia/reperfusion. Artif Organs. 39:126–133. 2015. View Article : Google Scholar : PubMed/NCBI

39 

Babiker FA, Al-Jarallah A and Joseph S: Understanding pacing postconditioning-mediated cardiac protection: A role of oxidative stress and a synergistic effect of adenosine. J Physiol Biochem. 73:175–185. 2017. View Article : Google Scholar : PubMed/NCBI

40 

Zhao ZQ: Oxidative stress-elicited myocardial apoptosis during reperfusion. Curr Opin Pharmacol. 4:159–165. 2004. View Article : Google Scholar : PubMed/NCBI

41 

Pu J, Yuan A, Shan P, Gao E, Wang X, Wang Y, Lau WB, Koch W, Ma XL and He B: Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia/reperfusion injury. Eur Heart J. 34:1834–1845. 2013. View Article : Google Scholar : PubMed/NCBI

42 

Zhu Z, Zhu J, Zhao X, Yang K, Lu L, Zhang F, Shen W and Zhang R: All-trans retinoic acid ameliorates myocardial ischemia/reperfusion injury by reducing cardiomyocyte apoptosis. PLoS One. 10:e01334142015. View Article : Google Scholar : PubMed/NCBI

43 

Xie H, Zhang J, Zhu J, Liu LX, Rebecchi M, Hu SM and Wang C: Sevoflurane post-conditioning protects isolated rat hearts against ischemia-reperfusion injury via activation of the ERK1/2 pathway. Acta Pharmacol Sin. 35:1504–1513. 2014. View Article : Google Scholar : PubMed/NCBI

44 

Szobi A, Rajtik T, Carnicka S, Ravingerova T and Adameova A: Mitigation of postischemic cardiac contractile dysfunction by CaMKII inhibition: Effects on programmed necrotic and apoptotic cell death. Mol Cell Biochem. 388:269–276. 2014. View Article : Google Scholar : PubMed/NCBI

45 

Ma N, Bai J, Zhang W, Luo H, Zhang X, Liu D and Qiao C: Trimetazidine protects against cardiac ischemia/reperfusion injury via effects on cardiac miRNA-21 expression, Akt and the Bcl-2/Bax pathway. Mol Med Rep. 14:4216–4222. 2016. View Article : Google Scholar : PubMed/NCBI

46 

Cui X, He Z, Liang Z, Chen Z, Wang H and Zhang J: Exosomes from adipose-derived mesenchymal stem cells protect the myocardium against ischemia/reperfusion injury through Wnt/β-catenin signaling pathway. J Cardiovasc Pharmacol. 70:225–231. 2017. View Article : Google Scholar : PubMed/NCBI

47 

Hu L, Cai N and Jia H: Pterostilbene attenuates myocardial ischemia-reperfusion injury via the phosphatidylinositol 3′-kinase-protein kinase B signaling pathway. Exp Ther Med. 14:5509–5514. 2017.PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Cheng B, Zhong JP, Wu FX, Li GL, Ruan QX, Luo G and Jiang H: Ebselen protects rat hearts against myocardial ischemia‑reperfusion injury. Exp Ther Med 17: 1412-1419, 2019.
APA
Cheng, B., Zhong, J., Wu, F., Li, G., Ruan, Q., Luo, G., & Jiang, H. (2019). Ebselen protects rat hearts against myocardial ischemia‑reperfusion injury. Experimental and Therapeutic Medicine, 17, 1412-1419. https://doi.org/10.3892/etm.2018.7089
MLA
Cheng, B., Zhong, J., Wu, F., Li, G., Ruan, Q., Luo, G., Jiang, H."Ebselen protects rat hearts against myocardial ischemia‑reperfusion injury". Experimental and Therapeutic Medicine 17.2 (2019): 1412-1419.
Chicago
Cheng, B., Zhong, J., Wu, F., Li, G., Ruan, Q., Luo, G., Jiang, H."Ebselen protects rat hearts against myocardial ischemia‑reperfusion injury". Experimental and Therapeutic Medicine 17, no. 2 (2019): 1412-1419. https://doi.org/10.3892/etm.2018.7089
Copy and paste a formatted citation
x
Spandidos Publications style
Cheng B, Zhong JP, Wu FX, Li GL, Ruan QX, Luo G and Jiang H: Ebselen protects rat hearts against myocardial ischemia‑reperfusion injury. Exp Ther Med 17: 1412-1419, 2019.
APA
Cheng, B., Zhong, J., Wu, F., Li, G., Ruan, Q., Luo, G., & Jiang, H. (2019). Ebselen protects rat hearts against myocardial ischemia‑reperfusion injury. Experimental and Therapeutic Medicine, 17, 1412-1419. https://doi.org/10.3892/etm.2018.7089
MLA
Cheng, B., Zhong, J., Wu, F., Li, G., Ruan, Q., Luo, G., Jiang, H."Ebselen protects rat hearts against myocardial ischemia‑reperfusion injury". Experimental and Therapeutic Medicine 17.2 (2019): 1412-1419.
Chicago
Cheng, B., Zhong, J., Wu, F., Li, G., Ruan, Q., Luo, G., Jiang, H."Ebselen protects rat hearts against myocardial ischemia‑reperfusion injury". Experimental and Therapeutic Medicine 17, no. 2 (2019): 1412-1419. https://doi.org/10.3892/etm.2018.7089
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team